Detection of glycosylation and iron-binding protein modifications using Raman spectroscopy
Literature Information
Victoria L. Brewster, Royston Goodacre
In this study we demonstrate the use of Raman spectroscopy to determine protein modifications as a result of glycosylation and iron binding. Most proteins undergo some modifications after translation which can directly affect protein function. Identifying these modifications is particularly important in the production of biotherapeutic agents as they can affect stability, immunogenicity and pharmacokinetics. However, post-translational modifications can often be difficult to detect with regard to the subtle structural changes they induce in proteins. From their Raman spectra apo-and holo-forms of iron-binding proteins, transferrin and ferritin, could be readily distinguished and variations in spectral features as a result of structural changes could also be determined. In particular, differences in solvent exposure of aromatic amino acids residues could be identified between the open and closed forms of the iron-binding proteins. Protein modifications as a result of glycosylation can be even more difficult to identify. Through the application of the chemometric techniques of principal component analysis and partial least squares regression variations in Raman spectral features as a result of glycosylation induced structural modifications could be identified. These were then used to distinguish between glycosylated and non-glycosylated transferrin and to measure the relative concentrations of the glycoprotein within a mixture of the native non-glycosylated protein.
Related Literature
The quasi-irreversible inactivation of cytochrome P450 enzymes by paroxetine: a computational approach
DOI: 10.1039/D0OB00529K
Metal-free late-stage C(sp2)–H functionalization of N-aryl amines with various sodium salts
Chandrashekar Mudithanapelli, Mi-hyun Kim
DOI: 10.1039/C9OB02217A
Base-controlled divergent synthesis of vinyl sulfones from (benzylsulfonyl)benzenes and paraformaldehyde
Fuhong Xiao, Yangling Hu, Huawen Huang, Fen Xu, Guo-Jun Deng
DOI: 10.1039/D0OB00362J
A visible-light-induced “on–off” one-pot synthesis of 3-arylacetylene coumarins with AIE properties
Xinjie Wu, Ming Jia, Mengmeng Huang, Jung Keun Kim, Zheng Zhao, Junkai Liu, Jinhu Xi, Yabo Li, Yangjie Wu
DOI: 10.1039/D0OB00479K
The impact of cation structure upon the acidity of triazolium salts in dimethyl sulfoxide
Nicholas Konstandaras, Michelle H. Dunn, Max S. Guerry, Christopher D. Barnett, Marcus L. Cole, Jason B. Harper
DOI: 10.1039/C9OB02258A
Asymmetric total syntheses of naturally occurring α,β-enone-containing RALs, L-783290 and L-783277 through intramolecular base-mediated macrolactonization reaction
Joy Chakraborty, Samik Nanda
DOI: 10.1039/D0OB00237B
1,2-cis-Selective glucosylation enabled by halogenated benzyl protecting groups
Dancan K. Njeri, Claude J. Pertuit, Justin R. Ragains
DOI: 10.1039/D0OB00373E
Biomimetic total syntheses of baefrutones A–D, baeckenon B, and frutescones A, D–F
Ji-Qin Hou, Jiang-Hong Yu, Heng Zhao, Ying-Ying Dong, Qiu-Shi Peng, Bao-Bao Zhang, Hao Wang
DOI: 10.1039/C9OB02490E
δ-Cyano substituted para-quinone methides enable access to unsymmetric tri- and tetraarylmethanes containing all-carbon quaternary stereocenters
Yue Qi, Fang Zhang, Lin Wang, Aili Feng, Rongxiu Zhu, Shutao Sun, Wei Li, Lei Liu
DOI: 10.1039/D0OB00551G
Toward the total synthesis of grayanane diterpene mollanol A by a Prins [3 + 2] strategy
Jianzhuang Miao, Yi-Xuan Zheng, Shi-Chao Lu, Shi-Peng Zhang, Ya-Ling Gong, Shu Xu
DOI: 10.1039/D0OB00160K
You might also like
What regulatory guidelines apply to 6-Bromo-2-methylimidazo[1,2-a]pyrimidine (CAS: 1111638-05-1)?
6-Bromo-2-methylimidazo[1,2-a]pyrimidine (CAS: 1111638-05-1) falls under various...
Are there alternatives to 1-Pyrrolidineethanol, β-methyl-α-phenyl-, (αS,βR) (CAS: 123620-80-4) in synthesis?
While there are no direct alternatives, similar compounds like 1-Pyrrolidineetha...
Is 4-Methyl-2,6-bis(2-methyl-2-propanyl)phenyl methylcarbamate (CAS: 1918-11-2) safe?
4-Methyl-2,6-bis(2-methyl-2-propanyl)phenyl methylcarbamate (CAS: 1918-11-2) is ...
How should 2-(3-Bromo-4-fluorophenyl)-1,3-dioxolane (CAS: 77771-04-1) be stored?
2-(3-Bromo-4-fluorophenyl)-1,3-dioxolane (CAS: 77771-04-1) should be stored in a...
What are the physical and chemical properties of 4,5,6,7-Tetrahydro-1H-indazole hydrochloride (CAS: 18161-11-0)?
4,5,6,7-Tetrahydro-1H-indazole hydrochloride is a white crystalline solid with a...
What is (2R)-1-Methoxy-3-phenyl-2-propanamine (CAS: 59919-07-2)?
(2R)-1-Methoxy-3-phenyl-2-propanamine is a chiral organic compound with the CAS ...
What industries use Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate (CAS: 56649-47-9)?
Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate is used in various industries...
What regulatory guidelines apply to 4-[(1E,3S)-1-(4-Hydroxyphenyl)-1,4-pentadien-3-yl]phenol (CAS: 17676-24-3)?
4-[(1E,3S)-1-(4-Hydroxyphenyl)-1,4-pentadien-3-yl]phenol (CAS: 17676-24-3) falls...
What industries use (S)-3-Amino-5-phenylpentanoic acid hydrochloride (CAS: 331846-97-0)?
(S)-3-Amino-5-phenylpentanoic acid hydrochloride is primarily used in the pharma...
How is 7-methoxy-1-benzothiophene-2-carboxylic acid (CAS: 88791-07-5) typically synthesized?
7-Methoxy-1-benzothiophene-2-carboxylic acid is typically synthesized by reactin...
Source Journal
Analyst

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.












![2-Methyl-2-propanyl 4-{2-fluoro-5-[(4-oxo-3,4-dihydro-1-phthalazinyl)methyl]benzoyl}-1-piperazinecarboxylate structure 2-Methyl-2-propanyl 4-{2-fluoro-5-[(4-oxo-3,4-dihydro-1-phthalazinyl)methyl]benzoyl}-1-piperazinecarboxylate structure](https://static.chemtradehub.com/structs/763/763114-04-1-65a9.webp)

![(3aS,6aS)-1-Methyloctahydropyrrolo[3,4-b]pyrrole structure (3aS,6aS)-1-Methyloctahydropyrrolo[3,4-b]pyrrole structure](https://static.chemtradehub.com/structs/877/877212-98-1-9157.webp)